The 9th Swiss-Scandinavian Bio-Business Seminar is organized by the Nordic countries in cooperation with Swiss partners. During this high-level partnering and investor conference, Swiss and Nordic biotech and pharmaceutical companies as well as investors meet in one-to-one meetings and present themselves in plenum.
The goal of the conference and by means of the Swiss-Nordic focus is to establish new contacts and networks.
- The previous SSBBS 2014 gathered more than 120 participants.
- A record of over 270 one-to-one meetings took place.
- In nearly 50% of the matchmaking meetings, further contact was planned or a cooperation considered
Confirmed participants include:
MS Ventures – Seventure Partner – Bay City Capital – Roche Venture Fund – Novartis Venture Fund – Sunstone Capital –Creathor Venture – Novo Seeds – Aravis – Endeavour Vision – Redalpine – Agire Invest – Index Ventures – Industrifonden – HBM Partners – Sarsia Seeds – NeoMed Management
Roche – Novartis – Pfizer – Takeda – MSD – Roche Diagnostics – Tillotts Pharma – Vifor Pharma – Alexion Pharma